Immune
repertoire is termed as the combination
of B cell receptors (BCR) and T cell receptors (TCR) that makes the organism's
adaptive immune system. It is widely used in biomarker discovery to improve the
success rate & cost-effectiveness of rational drug development. It is
highly applicable in infectious disease research, cancer immunotherapy, biomarker
discovery and asthma & allergy research. It assists researchers and
scientist in understanding or examining adaptive immune-mediated diseases.
According to study, “Global
Immune Repertoire Sequencing Market Size study, by Type (Assay Kits, Software
& Services), by Application (Biomarker Discovery, Infectious Diseases,
Vaccine Development & Efficacy, Cancer Immunotherapy, Autoimmune Diseases,
Transplant Rejection & Tolerance, Others), by End-User (Academic
Institutes, Research Center Diagnostic Laboratories, Others) and Regional
Forecasts 2018-2025” the key companies operating in the
global immune repertoire sequencing market are Oxford Nanopore Technologies
Ltd., Hoffmann-La Roche Ltd., Illumina Inc., Abvitro (Now Juno Therapeutics), Irepertoire,
Inc., Archerdx Inc., Adaptive Biotechnologies, Thermo Fischer Scientific,
Pacific Biosciences of California Inc., Takara Bio Inc., QIAGEN N.V., Agilent
Technologies, BGI. The key players are launching new products in the market, in
order to enhance its market share. Such innovative products are addressing numerous
clinical needs of patients, which are estimated to create conducive environment
for growth of the immune repertoire sequencing market.
Based on product type, immune repertoire sequencing market is segmented into analytical
software, assay, kits & reagent, instrument and services. Analytical
software includes BCR analysis solutions, TCR analysis solutions and TCR &
BCR analysis solutions. Assay, kits & reagent includes BCR kits (mouse BCR
kits and human BCR kits) and TCR kits (mouse TCR kits and human TCR kits).
Instrument products include polymerase chain reaction (PCR) and Next Generation
Sequencing (NGS). Additionally, services include sequencing services,
pre-sequencing services and data analysis services. Based on application,
market is segmented into biomarker discovery, infectious disease research,
autoimmune diseases, immunodeficiency identification, cancer immunotherapy,
vaccine development, asthma & allergy research and others. In addition,
based on end-users, market is segmented into diagnostic labs, research
institutes, pharmaceutical & biotech companies and others.
The immune repertoire sequencing market is
driven by growth in technological advancements for instance high-throughput
screening, high adoption rate of immune repertoire sequencing with new
technology, new software-based platforms, and growth in research &
development (R&D) activities, followed by new launches of novel products, rise
in prevalence of cancer and rapid increase in multiple therapeutic areas like
infectious diseases, pain management, cardiology, and oncology. However, high
cost related with sequencing platform & data analytics services and lack of
awareness about the cancer diseases treatment may impact the market. Moreover,
increase in international collaboration in immune repertoire sequencing
projects is a key opportunity for market.
Based on geography, the North-American region
dominates the immune repertoire sequencing market owing to high presence of key
players and rise in focus on developing novel technologies in the region. The
European and Asian-Pacific regions are predictable to exhibit higher growth due
to rapid growth in immune repertoire sequencing and rise in usage of immune
repertoire sequencing in oncology research over the forecast period. In near
future, it is projected that the market will be reached at rapid pace caused by
high prevalence of infectious diseases and rise in funding by the government
bodies to support international innovative projects & marketable innovative
products, services and processes during the forecast period.
For more
information on the research report, refer to below link:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur@kenresearch.com
+91-9015378249
No comments:
Post a Comment